Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
June 2027 167
2027-06-01
Primary completion Design and Rationale of the COLT Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07432529
2027-06-01
Primary completion SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07614230
2027-06-01
Primary completion Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07843004
2027-06-01
Primary completion The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07897409
2027-06-01
Primary completion Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07915687
2027-06
Study completion A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02098265
2027-06
Primary completion A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02098265
2027-06
2027-06
Primary completion Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04634916
2027-06
Study completion Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04670666
2027-06
2027-06
Primary completion Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05111288
2027-06
2027-06
2027-06
Study completion Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05589454
2027-06
Study completion COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05873881
2027-06
Primary completion COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05873881
2027-06
2027-06
Primary completion SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06001827
2027-06
Primary completion Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06027307
2027-06
Primary completion Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06029491
2027-06
Primary completion Dapagliflozin in STEMI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06174753
2027-06
Primary completion Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06226805
2027-06
Primary completion REstoration of VItamin D in Pulmonary Arterial Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06258850
2027-06
2027-06
Study completion Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06337838
2027-06
Study completion Adaptive Cognitive Training on Cognitive Function in Elderly Hypertension Patients in the Community Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06512922
2027-06
Study completion Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06524388
2027-06
Primary completion ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06608823
2027-06
Primary completion The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06700239
2027-06
2027-06
2027-06
Primary completion Landiolol in Mitral Valve Surgery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06793670
2027-06
2027-06
2027-06
Study completion Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06871774
2027-06
Primary completion Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06871774
2027-06
2027-06
Study completion Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06917664
2027-06
Study completion Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07022249
2027-06
Primary completion Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07022249
2027-06
2027-06
Study completion A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07142356
2027-06
2027-06
Primary completion AI-Assisted Interpretation of Cardiac CT in the Emergency Department Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07235657
2027-06
Study completion Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07241338
2027-06
Study completion The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07257822
2027-06
Primary completion The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07257822
2027-06
Study completion Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07267949
2027-06
2027-06
2027-06
2027-06
Study completion Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07391280
2027-06
Primary completion Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07391280
2027-06
2027-06
Study completion Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07520630
2027-06
Primary completion Multi-Site STARgraft (10401) Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07557862
2027-06
2027-06
Primary completion Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07898709
2027-06
2027-06
2027-06-08
Primary completion Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07295522
2027-06-09
Primary completion Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07817251
2027-06-11
2027-06-15
Primary completion Implementing Food Referrals for Equity and Sustained Health Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06661538
2027-06-15
Primary completion Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07566091
2027-06-16
Primary completion Gastric Feeding for the Prevention of Stroke-Associated Pneumonia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07630090
2027-06-17
Primary completion Prevent Cardiac Surgery Associated AKI Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06620523
2027-06-20
Primary completion CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05422534
2027-06-20
Primary completion Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07263308
2027-06-22
2027-06-22
2027-06-23
Study completion Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03445949
2027-06-25
Primary completion GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06578741
2027-06-30
Study completion Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01385176
2027-06-30
Primary completion Coronary Atherosclerosis T1-Weighted Characterization (CATCH) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03504956
2027-06-30
2027-06-30
Study completion NobleStitch EL STITCH Trial is a PFO Comparative Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04339699
2027-06-30
Study completion Firehawk Rapamycin Target Eluting Coronary Stent North American Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04562532
2027-06-30
Primary completion The Arteriovenous Vascular (AV) ACCESS Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04646226
2027-06-30
Study completion Sonification Techniques for Gait Training Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04876339
2027-06-30
2027-06-30
Primary completion Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05283356
2027-06-30
Study completion Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05337241
2027-06-30
Primary completion Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05337241
2027-06-30
Study completion GENOSS Coronary Stent Clinical Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05444452
2027-06-30
Primary completion GENOSS Coronary Stent Clinical Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05444452
2027-06-30
2027-06-30
Primary completion Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06092736
2027-06-30
2027-06-30
Study completion Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06250712
2027-06-30
Primary completion Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06250712
2027-06-30
Primary completion Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06284642
2027-06-30
2027-06-30
2027-06-30
2027-06-30
Study completion Intravenous Thrombolysis and NOAC Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06749834
2027-06-30
Primary completion Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06841965
2027-06-30
Primary completion Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06841978
2027-06-30
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2018-12-31
Primary completion Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03045562
2018-12-31
Study completion Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03047772
2018-12-31
Primary completion Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03047772
2018-12-31
2018-12-31
2018-12
Primary completion Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03072082
2018-12
Primary completion Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03072121
2018-12
Study completion Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03072225
2018-12
Study completion Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03112538
2018-12
Primary completion Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03112538
2018-12
Primary completion Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03121053
2018-12
Primary completion Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03377335
2018-12-31
Study completion Effect of Hyperuricaemia on Chronic Renal Disease Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03425708
2018-12-31
Primary completion Effect of Hyperuricaemia on Chronic Renal Disease Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03425708
2018-12-31
Study completion the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03427944
2018-12-31
Primary completion the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03427944
2018-12-31
Study completion Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03602742
2018-12-31
Primary completion Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03602742
2019-01-30
Primary completion COmprehensive Remote Ischemic Conditioning in Myocardial Infarction Registry record
Expected 2019-01-30; that period ended on 2019-01-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03233919
2019-01-30
Study completion The Effects of Empagliflozin on Arterial Wall Characteristics Registry record
Expected 2019-01-30; that period ended on 2019-01-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03639545
2019-01-30
Primary completion Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients Registry record
Expected 2019-01-30; that period ended on 2019-01-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03673241
2019-01
Primary completion Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01001962
2019-01
Study completion EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01084993
2019-01
Study completion REmote iSchemic Conditioning in acUtE BRAin INfarction Study Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02189928
2019-01
Primary completion REmote iSchemic Conditioning in acUtE BRAin INfarction Study Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02189928
2019-01
Study completion REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02580955
2019-01
Primary completion REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02580955
2019-01
Study completion Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC) Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02826200
2019-01
Study completion SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02959606
2019-01
Primary completion SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02959606
2019-01
Study completion Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03121053
2019-01
Study completion Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03377335
2019-01
Primary completion Optimizing Patient Usability Experience for Chronic Care Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03628963
2019-01
Study start Trial for MicroPort's Firesorb BVS: FUTURE-III Registry record
Expected 2019-01; that period ended on 2019-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03660202
2019-02-01
Study start Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety Registry record
Expected 2019-02-01; that period ended on 2019-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03667677
2019-02-01
Study start CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot Registry record
Expected 2019-02-01; that period ended on 2019-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03808428
2019-02-23
Study start Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System Registry record
Expected 2019-02-23; that period ended on 2019-02-23.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03788590
2019-02-28
Study completion Optimised Pacing Program Registry record
Expected 2019-02-28; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01819662
2019-02
Study completion External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02054416
2019-02
Study completion Once-a-day Tacrolimus Conversion Study: The OneTAC Trial Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02545972
2019-02
Primary completion Reappraisal of GIK in Acute STEMI by Pre-hospital Administration Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02591927
2019-02
Study completion Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03005470
2019-02
Primary completion Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03005470
2019-02
Study completion Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03072082
2019-02
Study completion Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03072121
2019-02
Study completion Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF) Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03096613
2019-02
Primary completion Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF) Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03096613
2019-02-28
Primary completion Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy Registry record
Expected 2019-02-28; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03262363
2019-02
Study completion DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03633890
2019-02
Primary completion DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris Registry record
Expected 2019-02; that period ended on 2019-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03633890
2019-03-01
Study start Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Registry record
Expected 2019-03-01; that period ended on 2019-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03658031
2019-03-01
Primary completion Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population Registry record
Expected 2019-03-01; that period ended on 2019-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03696940
2019-03-01
Study start Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery Registry record
Expected 2019-03-01; that period ended on 2019-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03838328
2019-03-06
Study start AUSTrian Randomized Interventional Study on Dialysis Accesses Registry record
Expected 2019-03-06; that period ended on 2019-03-06.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03764358
2019-03-15
Primary completion Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement Registry record
Expected 2019-03-15; that period ended on 2019-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03440268
2019-03-24
Primary completion CPAP for OSA on Myocardial Salvage After pPCI for STEMI Patients Registry record
Expected 2019-03-24; that period ended on 2019-03-24.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03444857
2019-03-28
Study completion Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients Registry record
Expected 2019-03-28; that period ended on 2019-03-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03673241
2019-03-30
Primary completion Tecarfarin Anti-Coagulation Trial (TACT) Registry record
Expected 2019-03-30; that period ended on 2019-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02522221
2019-03-30
Primary completion H-Type Hypertension Precision Medicine Trial Registry record
Expected 2019-03-30; that period ended on 2019-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03472508
2019-03
Primary completion Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke. Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01561677
2019-03
Primary completion Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST) Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01930773
2019-03
Study completion A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01942070
2019-03
Study start Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02323620
2019-03
Primary completion Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02425371
2019-03
Primary completion Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02502110
2019-03
Study completion Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02508714
2019-03
Study completion Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02538978
2019-03
Study completion Spironolactone in Atrial Fibrillation Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02673463
2019-03
Primary completion Once-daily Fixed Combination of Three Antihypertensive Drugs Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02710539
2019-03
Primary completion Low-dose Combination of Three Antihypertensive Drugs Registry record
Expected 2019-03; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02710552
2019-03-31
Study completion A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Registry record
Expected 2019-03-31; that period ended on 2019-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02920593
2019-04-01
Primary completion Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure Registry record
Expected 2019-04-01; that period ended on 2019-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03437226
2019-04-01
Study start Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) Registry record
Expected 2019-04-01; that period ended on 2019-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03786757
2019-04-01
2019-04-01
Study start CUHK Jockey Club HOPE 4 Care Programme - FES Bike Registry record
Expected 2019-04-01; that period ended on 2019-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03848624
2019-04-20
Study start Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology Registry record
Expected 2019-04-20; that period ended on 2019-04-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03917563
2019-04
Primary completion Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus Registry record
Expected 2019-04; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02162550
2019-04
Primary completion Optimized Remote Ischemic Conditioning (RIC) Treatment for Patients With Chronic Cerebral Ischemia Registry record
Expected 2019-04; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03105141
2019-04-30
Primary completion Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD Registry record
Expected 2019-04-30; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03150667
2019-04-30
Primary completion Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan Registry record
Expected 2019-04-30; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03231982
2019-04-30
Study completion Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy Registry record
Expected 2019-04-30; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03262363
2019-04
Study completion Remote Ischemic Conditioning Using the autoRIC Registry record
Expected 2019-04; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03318575
2019-04
Primary completion Remote Ischemic Conditioning Using the autoRIC Registry record
Expected 2019-04; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03318575
2019-04-30
Study completion Evaluation of Nail Fold Microcirculation in CKD Registry record
Expected 2019-04-30; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03682952
2019-04-30
Primary completion Evaluation of Nail Fold Microcirculation in CKD Registry record
Expected 2019-04-30; that period ended on 2019-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03682952
2019-05-01
Study start Heart Monitoring Device After Acute Myocardium Infarction Registry record
Expected 2019-05-01; that period ended on 2019-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03494751
2019-05-10
Study completion An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes Registry record
Expected 2019-05-10; that period ended on 2019-05-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03216564
2019-05-10
Primary completion An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes Registry record
Expected 2019-05-10; that period ended on 2019-05-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03216564
2019-05-28
Primary completion Effect of External Counter Pulsation on Coronary Artery Disease Registry record
Expected 2019-05-28; that period ended on 2019-05-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03075124
2019-05
Study completion Performance of the CARDIOGARD Cannula Registry record
Expected 2019-05; that period ended on 2019-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02764645
2019-05
2019-05
2019-05
Study completion New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry Registry record
Expected 2019-05; that period ended on 2019-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT02820779
2019-05
Primary completion New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry Registry record
Expected 2019-05; that period ended on 2019-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT02820779
2019-05
Study completion A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes Registry record
Expected 2019-05; that period ended on 2019-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02861261
2019-05
Study completion Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting Registry record
Expected 2019-05; that period ended on 2019-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03049085
2019-05-31
Primary completion Effect of External Counter Pulsation on Ischemic Stroke Registry record
Expected 2019-05-31; that period ended on 2019-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03075137
2019-05-31
Study completion Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan Registry record
Expected 2019-05-31; that period ended on 2019-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03231982
2019-06-01
Primary completion Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies Registry record
Expected 2019-06-01; that period ended on 2019-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03578848
2019-06-01
Study start Trial of Oral Melatonin in Elevated Blood Pressure Registry record
Expected 2019-06-01; that period ended on 2019-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03764020